/**/ document.writeln("\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
MarketsQuoteDepth/LIIChartsNewsHistorical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Amicus Therapeutics Inc. (FOLD) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 3.83\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n  \n\n -0.15\n\n (-3.77%)\n\n \n\n \n\n \n\n \n\n Volume: 41.82 k\n\n \n\n \n\n\n\n 4:00 PM EST Nov 20, 2009\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
June 30,2009
\n \n
Close: \n 13.50\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
October 30,2009
\n \n
Close: \n 3.681\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
3.83
\n 		\n\n \n \n \n
Change $
\n \n 0.15\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 3.77%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
N/A
\n 		\n \n \n \n\n
Bid Size
0
\n 		\n \n \n \n
Ask
N/A
\n\n 		\n \n \n \n
Ask Size
0
\n
\n \n \n \n
Open
3.94
\n 		\n \n \n \n
High
4.03
\n 		\n\n \n \n \n
Low
3.76
\n 		\n \n\n \n \n
Prev Close
3.98
\n
\n \n\n \n \n
Last Trade
11/20/09
\n 		\n \n \n \n
Volume
41.82 k
\n 		\n \n \n \n
\n
52 Wk Hi
13.50
\n 		\n\n \n \n \n
52 Wk Low
3.681
\n
\n \n\n \n \n
Market Cap
86.74 m
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
22,647,869
\n 		\n \n \n \n
EPS (TTM)
-2.37
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
NASDAQ (NSD)
\n
\n
\n
\n
\n
\n \n
Exchange
NSD
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Amicus Therapeutics Inc.\n\n \n\n  (FOLD) \n\n \n\n \n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking &\nFinance
\n\n
Capital Gains
\n
Mergers &\nAcquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary\nFund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for FOLD\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Nov 12, 2009
\n\n \n\n\n\n
8:01 AM\n\n\n\n Amicus Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009 - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 03, 2009
\n\n \n\n\n\n
8:02 AM\n\n\n\n Amicus Therapeutics Appoints Margaret G. McGlynn, R.Ph., to Board of Directors - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 02, 2009
\n\n \n\n\n\n
9:00 AM\n\n\n\n Phase Forward to Host Eighth Annual International Users Conference, November 3-5, Boston - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Oct 29, 2009
\n\n \n\n\n\n
4:05 PM\n\n\n\n Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Oct 26, 2009
\n\n \n\n\n\n
8:02 AM\n\n\n\n Amicus Therapeutics Announces Third Quarter 2009 Financial Results Release Date - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Oct 02, 2009
\n\n \n\n\n\n
4:05 PM\n\n\n\n Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Sep 30, 2009
\n\n \n\n\n\n
8:01 AM\n\n\n\n Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Sep 10, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14, 2009 - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Aug 10, 2009
\n\n \n\n\n\n
6:50 AM\n\n\n\n StockPreacher.com Issues Trading Outlook for Keryx Biopharmaceuticals Inc. - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Aug 05, 2009
\n\n \n\n\n\n
4:00 PM\n\n\n\n Amicus Therapeutics Announces Second Quarter 2009 Financial Results - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jul 29, 2009
\n\n \n\n\n\n
8:01 AM\n\n\n\n Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Jun 22, 2009
\n\n \n\n\n\n
8:02 AM\n\n\n\n Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, May 11, 2009
\n\n \n\n\n\n
8:02 AM\n\n\n\n Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009 - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, May 07, 2009
\n\n \n\n\n\n
4:00 PM\n\n\n\n Amicus Therapeutics Announces First Quarter 2009 Financial Results - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Apr 30, 2009
\n\n \n\n\n\n
8:01 AM\n\n\n\n Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Mar 30, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Sat, Mar 28, 2009
\n\n \n\n\n\n
7:15 AM\n\n\n\n Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Mar 25, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Mar 11, 2009
\n\n \n\n\n\n
8:01 AM\n\n\n\n Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009 - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Feb 27, 2009
\n\n \n\n\n\n
9:30 AM\n\n\n\n Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease - PR Newswire
\n\n More News for FOLD >>
\n\n
\n\n
\n\n\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n\n DL+   Realtime BATS,  \n\n EOD   End Of Day,  \n\n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");